83 results about "Media otitis" patented technology

Apparatuses and methods for mobile imaging and image analysis. In particular, described herein are methods and apparatuses for assisting in the acquisition and analysis of images of the tympanic membrane to provide information that may be helpful in the understanding and management of disease, such ear infection (acute otitis media). These apparatuses may guide or direct a subject in taking an image of a tympanic membrane, including automatically detecting which direction to adjust the position of the apparatus to capture an image of the tympanic membrane and automatically indicating when the tympanic membrane has been imaged.

Chronic Otitis Media with Effusion (COME), Recurrent Acute Otitis Media (RAOM), cholesteatoma, and other bacterial ear conditions may be treated by applying a solvating system containing greater than 0.2 wt. % surfactant to a bacterial biofilm in the middle or inner ear, disrupting the biofilm, and applying a protective layer of a polymeric film-forming medical sealant.

The present invention is directed to a novel method for preventing or treating respiratory infections and acute otitis media in infants. The method comprises the administration of a therapeutically effective amount of a Bifidobacteria strain and an adherence-promoting probiotic, such as LGG, to the infant.

The present application provides sodium channel blockers exemplified by the following structure:The compounds of the invention useful for treating chronic bronchitis, cystic fibrosis, sinusitis, vaginal dryness, dry eye, Sjogren's disease, distal intestinal obstruction syndrome, dry skin, esophagitis, dry mouth (xerostomia), nasal dehydration, ventilator-induced pneumonia, asthma, primary ciliary dyskinesia, otitis media, chronic obstructive pulmonary disease, emphysema, pneumonia, constipation, and chronic diverticulitis, for example.

The invention relates to the polynucleotide sequence of a nontypeable stain of Haemophilus influenzae (NTHi) and polypeptides encoded by the polynucleotides and uses thereof. The invention also relates to NTHi genes which are upregulated during or in response to NTHi infection of the middle ear and / or the nasopharynx.

Compositions comprising therapeutically effective amounts of lamellar bodies for the modification of linear macromolecules are disclosed. These lamellar compositions are useful in the treatment of conditions or diseases characterized by a preponderance of heavy mucous secretions, such as otitis media, cystic fibrosis, bronchitis, sinusitis and nasal congestion. Methods of treating these diseases and conditions by administering a therapeutically effective amount of a composition to a patient requiring such treatment are also disclosed.

The present invention relates to a otitis media diagnosis system using terahertz electromagnetic waves, which can diagnose otitis media using terahertz electromagnetic waves in a non-invasive manner, and which can accurately diagnose otitis media by acquiring images on the tympanic cavity using terahertz electromagnetic waves with excellent transmittance, and which can quickly and accurately divide exudative otitis media and suppurative otitis media using terahertz electromagnetic waves that are sensitive to moisture, and which is safe to a body using terahertz electromagnetic waves. The otitis media diagnosis system includes a terahertz probe including a generating unit for radiating terahertz electromagnetic waves from the outside of an ear toward a tympanic cavity and a detection unit for detecting the reflected terahertz electromagnetic waves reflected from the tympanic cavity.

An OCT apparatus and method for characterization of a fluid adjacent to a tympanic membrane has a low coherence source which is coupled to a splitter which has a measurement path and a reference path. The reference path is temporally modulated for length, and the combined signals from the reference path and the measurement path are applied to a detector. The detector examines the width of the response and the time variation when an optional excitation source is applied to the tympanic membrane, the width of the response and the time variation forming a metric indicating the viscosity of a fluid adjacent to the tympanic membrane being measured.

The invention discloses a compound ear dropping liquid for treating suppurative otitis media. An inventor treats the suppurative otitis media by applying traditional Chinese medical science which haseffects of clearing and activating the channels and collaterals, activating blood and dissolving stasis, removing putrid tissue and healing cutis, softening dilated blood vessels and promoting dead nerve cells to be regenerated, removing tinnitus and recovering auditory nerves, thereby removing the pain of patients without toxic side effect. The compound ear dropping liquid for treating the suppurative otitis media is prepared by mixing Chinese herbal medicines, i.e. hydrogen peroxide, lily, talci, almond, akebiaquinata, lophatherum gracile, herba schizonepetae, liquorice, borneol, platycodonroots, antelope horn powder, gentian, honeysuckle, wild honeysuckle leaves, rhizoma anemarrhenae, borax, pearl barley, frankincense, muskiness, pennyroyal, glacialin, and the like.

The invention discloses a traditional Chinese medicine compound medicine composition for treating otitis media and a preparation process thereof. The traditional Chinese medicine compound medicine composition for treating otitis media is mainly composed of golden thread, borneol, calcined alum, alum, fossilized and cuttlebone. The ear drops are characterized by rapid dry ear, high efficacy, short course of treatment, no significant side effects, safe medication and so on.

The invention discloses a drug composition, which comprises the following parts: Amoxicillin with effective drug dosage or Amoxicillin sodium salt and beta-lactamase inhibitor and hydrobromic suo or hydrobromic suo alcaine. The invention reinforces the treating effect within short path to possess precise dosage and convenient clinic usage, which can treat acute bronchitis, asthmatic bronchitis, acute paroxysm of chronic bronchitis, bronchial expansion and bronchial asthma, otitis media, pharyngitis, nasal sinusitis, pneumococcosis and tonsillitis.

Peptides for the treatment of inflammation, and therapeutic uses and methods of using the same are disclosed. Peptides including a transducing sequence are effective for inhibiting cytokine activity and TNF-α secretion through interaction with toll-like receptor signaling pathways. Experiments are described illustrating the efficacy of the compounds in treating otitis media, noise-induced hearing loss, age-related hearing loss, and improvement of ordinary hearing.

The present invention provides compositions and methods for delivery of therapeutic agents across an barrier. The compositions include a therapeutic agent (e.g., antimicrobial agent, antibiotic, or anesthetic agent), a permeation enhancer which increases the flux of the therapeutic agent across the barrier, and a matrix forming agent. The matrix forming agent forms a gel at a suitable gelation temperature and rheological properties for use in drug delivery, and in some cases, the gelation temperature and rheological properties are not significantly changed from those of the composition withoutthe permeation enhancer. The invention also provides a matrix forming agent and compositions thereof. Such compositions are particularly useful in the treatment of otitis media. Methods of treatment,methods of delivery, and kits for the compositions described herein are also provided.

The invention relates to medicine powder for treating acute and chronic suppurative otitis media and a preparation method. The medicine powder comprises the following ingredients in parts by mass: 1-3 parts of borneol, 1-3 parts of musk, 1-3 parts of minium, 1-3 parts of dried alum and 1-3 parts of fossil fragment. The method comprises the steps of selecting the high-quality and clean borneol, the musk, the minium, the dried alum and the fossil fragment according to the parts by mass, picking outresidual impurities and dust respectively for future use, and B, grinding the medicines into extra fine powder, putting in a sterile room for ultraviolet sterilization, and then subpackaging the sterilized extra fine powder equivalently (sealing with a porcelain bottle) to obtain the finished product of the medicine powder.

The invention discloses a medicine for treating otitis media. The medicine comprises 2-6g of Oldenlandia diffusa, a centipede, 3-8g of snake slough, 2-6g of Bat Dung, 10-20g of fructus psoraleae, 3-8g of kelp, 5-10g of cotton seed, 4-8g of herba epimedii, 10-20g of honeysuckle, 5-12g of fructus forsythiae and 10-24g of glycerin. The medicine can be daubed into the auditory meatus for treatment. The medicine has a good effect of treating the otitis media, an external application method is adopted, excretion of liver and kidney can be reduced, and the burden of organs in the body can be reduced.

The invention relates to a lomefloxacin aspartate hydrate and the preparation, as well as the usage. The lomefloxacin aspartate hydrate of the invention (the molecular formula is C17H19F2N3O3.C4H7NO4.nH2O, n is equal to 0.5 to 2.5), the lomefloxacin aspartate hydrate of the invention is the fluoroquinolone antibacterial agent used for human or animal respiratory infection, genitourinary infection, gastrointestinal tract bacterial infection, abdominal infection, bile duct infection, typhoid and other infections, bone and joint infection, skin soft tissue infection, sepsis and other systemic infection, other infections, such as paranasal sinusitis, otitis media, blepharitis and so on which are caused by Gram positive or negative bacteria and sensitive bacteria, the invention has the advantages of stable existence, easy storage and transportation and convenient preparation of the pharmaceutical preparations.

The medicine for treating oritis media is prepared with Tianlong, Chinese goldthread, gallnut and musk. It is easy to use and may be applied in hospital or household. It has high curative effect and no side effect.

A medicine for treating otitis media is mainly prepared from Chinese medicinal herbs of radix semiaquilegiae, alisma orientale, salvia miltiorrhiza, oldenlandia diffusa, wild chrysanthemum flower, etc.; the Chinese medicinal herbs are decocted repeatedly by slow fire, liquid medicine is concentrated into dense paste, and then conventional minor ingredients are added to be prepared into tablets, capsules, pills, granules, powders, injections or paste accepted by clinic. The medicine of the invention has the efficacies of clearing away heat and toxic material, removing swelling and masses, activating stasis and relieving pain, can treat various kinds of otitis media, and has the advantages of favorable treatment effect, no toxic and side effect, low treatment cost, etc.

The invention discloses a vinegar drink for treating otitis media. The vinegar drink is prepared from the following main raw materials in parts by weight: 9-15 parts of semen brassicae, 6-12 parts of corn, 10-15 parts of liquorice, 5-10 parts of honeysuckle, 6-12 parts of borneol, 15-60 parts of lalang grass rhizome, 5-15 parts of mint, 4.5-9 parts of yellow croaker ear-stone, 5-15 parts of radix bupleuri, 12-15 parts of fructus forsythiae, 5-15 parts of galium aparine and 60-100 parts of vinegar. The vinegar drink disclosed by the invention treats both symptoms and root causes, can be poured into the local part in the ear in a small amount, has high penetrability and absorption capacity, straightly reaches the affected part, is fast and lasting in curative effect, convenient for external use, safe and reliable, can achieve the effects of sterilizing and diminishing inflammation when oral administration is performed, really realizes treatment on both symptoms and root causes, does not have any side effect and has a good effect of treating the otitis media.

The invention discloses a traditional Chinese medicine compound medicine composition for treating otitis media and a preparation process thereof. The traditional Chinese medicine compound medicine composition for treating otitis media is mainly composed of golden thread, borneol, calcined alum, alum, fossilized and cuttlebone. The ear drops are characterized by rapid dry ear, high efficacy, shortcourse of treatment, no significant side effects, safe medication and so on.

The invention belongs to the technical field of medicine, particularly relates to traditional Chinese medicine composition for treating otitis media, and aims at making up defects of the prior art and relieving pain of patients suffering the otitis media. The traditional Chinese medicine composition has remarkable anti-inflammation analgesic activity, is obvious in treatment effect, safe and reliable, and has wide clinical application prospect.

The present invention relates to special high effect suppurative otitis powder for suppurative otitis media treatment and a preparation method thereof. The high effect suppurative otitis powder is characterized in that the powder comprises the following raw materials, by weight, 15-20 parts of fried rheum powder, 15-20 parts of fried longleaf garden burnet root powder, 16-22 parts of borax, 16-22 parts of weathered sodium sulfate, and 11-16 parts of borneol. The preparation method comprises: frying rheum and longleaf garden burnet root into a brown color, wherein a certain drug nature is remained; respectively grinding and screening through a 180 mesh sieve, and weighing the rheum powder and the longleaf garden burnet root powder according to a certain weight ratio to be spare; weighing borax, weathered sodium sulfate and borneol according to a certain weight ratio to be spare; finally uniformly stirring the weighed rheum powder, the weighed longleaf garden burnet root powder, the borax powder, the weathered sodium sulfate and the borneol powder, filling into a bottle, sealing to obtain the finished product, and placing in a cool place to be spare. The high effect suppurative otitis powder has good effects of heat clearing, blood cooling, bacterial resistance, detoxifying, convergence and tissue regeneration promoting, wherein suppurative otitis media can be cured after use of the high effect suppurative otitis powder 1-2 times.

A pharmaceutical formulation for treating otitis media is characterized by being composed of 10g of Radix Dipsaci, 10g of Fructus Gardeniae, 10g of Indigo Naturalis, 10g of Radix Scutellariae, 10g of honeysuckle and 10g of Radix Platycodonis. A preparation method includes: weighing the medicinal materials, soaking in cold water for 20min, boiling, decocting over a slow fire for 20min, and pouring out; adding cold water, boiling and decocting for 20min, mixing the two decoctions, and dividing into two parts which are supposed to be taken warm in the morning and in the evening respectively. The pharmaceutical formulation for treating otitis media is applicable to treatment of otitis media and solves the problems of side effects, addiction, long treatment time, high withdrawal relapse rate, failure in radical treatment and the like of existing medicines for treating otitis media.

The invention discloses an otitis media auditory meatus medicine spraying therapeutic instrument capable of automatically spraying medicines. The otitis media auditory meatus medicine spraying therapeutic instrument comprises a work box, wherein a work cavity is formed in the work box, a first communication cavity penetrating through the inner wall of the upper side of the work cavity is formed inthe inner wall of the upper side of the work cavity, and an auditory meatus stabilizing pipe is fixedly arranged on the upper end surface of the work box; and a second communication cavity penetrating through the upper end surface and the lower end surface of the auditory meatus sterilizing pipe is arranged in the auditory meatus sterilizing pipe. When the otitis media auditory meatus medicine spraying therapeutic instrument is used, only the instrument needs to be inserted into the auditory meatus and then is started, the instrument can be provided with a protection device at the tail end ofthe auditory meatus, and then uniform medicine spraying is performed in the auditory meatus through centrifugal force. Due to high automation of the instrument, a patient can independently finish treatment of otitis media, the treatment difficulty is reduced, and complications are avoided.

The invention provides a drug for treating otitis media. The drug comprises the following components in parts by weight: 8-12 parts of honeysuckle, 6-10 parts of weeping forsythia capsule, 6-11 parts of common andrographis herb, 4-9 parts of gentian, 7-15 parts of grassleaf sweetflag rhizome and 8-12 parts of liquorice. The drug has the advantages and positive effects of good curative effects, small side effects and low treatment cost.

Systems and methods are presented for the diagnosis of middle ear pathological conditions based on spectral signatures. Preferred embodiments provide for detection of one or more analytes from the tympanic membrane. Devices use spectral measurements including spectral imaging to non-invasively identify middle ear pathological conditions including cholesteatoma and acute otitis media by providing real-time information of differentially expressed molecules. Devices and methods can also be used to non-invasively detect and quantify blood analytes from the tympanic membrane.

The present invention relates to a otitis media diagnosis system using terahertz electromagnetic waves, which can diagnose otitis media using terahertz electromagnetic waves in a non-invasive manner, and which can accurately diagnose otitis media by acquiring images on the tympanic cavity using terahertz electromagnetic waves with excellent transmittance, and which can quickly and accurately divide exudative otitis media and suppurative otitis media using terahertz electromagnetic waves that are sensitive to moisture, and which is safe to a body using terahertz electromagnetic waves. The otitis media diagnosis system includes a terahertz probe including a generating unit for radiating terahertz electromagnetic waves from the outside of an ear toward a tympanic cavity and a detection unit for detecting the reflected terahertz electromagnetic waves reflected from the tympanic cavity.

The invention relates to the technical field of pharmaceutical production, and provides a traditional Chinese medicine formula for treating otitis media and a preparation method of the traditional Chinese medicine formula. The formula is prepared from the components in parts by weight: 10-50 parts of rhizoma coptidis, 20-40 parts of radix scutellariae, 15-35 parts of cortex phellodendri chinensis,20-40 parts of radix gentianae, 1-10 parts of calculus bovis and 1-10 parts of borneolum syntheticum. The preparation method comprises the steps that each formula component is ground into powder, then filtering, sterilization and disinfection are performed, finally bottling is performed, and traditional Chinese medicine for treating otitis media is obtained. The rhizoma coptidis in the formula has the effects of clearing away heat and drying dampness, purging fire for removing toxin and externally treating eczema and discharge of pus of ear canal; the radix scutellariae has the effects of clearing away heat and drying dampness and purging fire for removing toxin; the cortex phellodendri chinensis has the effects of clearing away heat and drying dampness, purging fire and eliminating steamand detoxifying and treating sores; the radix gentianae has the effects of clearing away heat and drying dampness and purging liver-fire and gallbladder fire and used for treating jaundice due to damp-heat and tinnitus and deafness; the calculus bovis has the functions of clearing away heat and toxic materials, treating analgesic, resisting to inflammation, resisting to pathogen microorganism andresisting to oxidation; and the borneolum syntheticum is used for clearing away heat and dispersing toxin and used for treating pharyngitis and deafness. The traditional Chinese medicine is rigorousin components and reasonable in formula, and can effectively treat otitis media.